Use of Injection Diclofenac Sodium (IM) and Injection Diclofenac Sodium (IM) with Paracetamol (oral) for post operative pain in pregnant women after Elective Cesarean Section under Spinal Anaesthesia - A Randomised Controlled Trial.

Post operative analgesia with Injection Diclofenac Sodium (IM) and Injection Diclofenac Sodium (IM) with Paracetamol (oral) in pregnant women after Elective Cesarean Section under Spinal Anaesthesia - A Randomised Controlled Trial.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037505

Enrollment

Registered

2021-10-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: Injection Diclofenac Sodium IM with Tablet Paracetamol oral: 75mg Injection Diclofenac Sodium is given intramuscular 8th hourly for 24 hours post op along with Tablet Paracetamol 1000mg

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women of American Society of Anesthesiologists (ASA) physical status II Gestation age of 37 weeks and above. Singleton pregnancies.

Exclusion criteria

Exclusion criteria: Pre existing significant maternal medical illness including asthma, gastric ulcers, bleeding diathesis, liver diseases, renal diseases, chronic pain syndrome. Pre existing significant maternal obstetric illness including chorioamnionitis, PIH etc. Patients receiving analgesics in the previous 24 hours before surgery. Contraindications to Spinal Anaesthetia. Drug allergy. Patient refusal.

Design outcomes

Primary

Measure	Time frame
Intensity of pain using NRS (0-10) Timepoint: Over 24 hours of post operative period.	—

Secondary

Measure	Time frame
Overall functional recoveryTimepoint: Over 24 hours of post operative period.	—

Countries

India

Contacts

Public ContactOmkar Anil Patil

VIMS

dr.parimaladu@gmail.com9742530338

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026